Search
Now showing items 1-10 of 278
Preprint
Cabotegravir is not associated with weight gain in HIV-uninfected individuals in HPTN 077
| Date Issued:
2019 | Copyright:
open access
Article
A review of the safety and tolerability profile of the next-generation NNRTI etravirine
| Date Issued:
2010 | Copyright:
restricted access
Article
HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts
| Date Issued:
2015 | Copyright:
open access
Article
Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients
| Date Issued:
2011 | Copyright:
restricted access
Article
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
| Date Issued:
2011 | Copyright:
restricted access
Article
Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials
| Date Issued:
2010 | Copyright:
restricted access
Article
Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial
| Date Issued:
2010 | Copyright:
open access
Article
Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men
| Date Issued:
2013 | Copyright:
open access
Article
Long-Term Efficacy, Safety, and Tolerability of Rilpivirine (RPV, TMC278) in HIV Type 1-Infected Antiretroviral-Naive Patients: Week 192 Results from a Phase IIb Randomized Trial
| Date Issued:
2012 | Copyright:
restricted access
Article
Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study
| Date Issued:
2013 | Copyright:
restricted access